PMID- 18849642 OWN - NLM STAT- MEDLINE DCOM- 20081217 LR - 20081030 IS - 1424-3911 (Electronic) IS - 1424-3903 (Linking) VI - 8 IP - 6 DP - 2008 TI - Protease activation, pancreatic leakage, and inflammation in acute pancreatitis: differences between mild and severe cases and changes over the first three days. PG - 600-7 LID - 10.1159/000161011 [doi] AB - BACKGROUND/AIMS: The pathophysiology of acute pancreatitis (AP) may be studied using markers of protease activation (active carboxypeptidase B (aCAP), the activation peptide of carboxypeptidase B (CAPAP)), leakage of pancreatic enzymes (trypsinogen-2, procarboxypeptidase B (proCAP), amylase), and inflammation (monocyte chemoattractant protein-1 (MCP-1), CRP). METHODS: This prospective study included 140 cases of AP. Mild (n = 124) and severe (n = 16) cases were compared with respect to serum levels of trypsinogen-2, proCAP, amylase, aCAP, CAPAP (serum/urine), MCP-1 (serum/urine) and CRP on days 1, 2 and 3 from onset of symptoms. All patients with information on all 3 days were included in a time-course analysis (n = 44-55, except amylase: n = 27). RESULTS: High levels in severe versus mild cases were seen for trypsinogen-2, CAPAP in serum and urine, and MCP-1 in serum on days 1-3. No differences were seen for proCAP, amylase and aCAP. MCP-1 in urine was significantly elevated on day 1-2, and CRP on day 2-3. CAPAP and MCP-1 levels peaked early and stayed elevated for 48 h in serum. CONCLUSION: Protease activation and inflammation are early events in AP, with high levels of these markers within 24 h. Protease activation declines after 48 h, whereas inflammation is present for a longer time. CI - Copyright 2008 S. Karger AG, Basel and IAP. FAU - Regner, S AU - Regner S AD - Department of Surgery, Malmo University Hospital, Lund University, Lund, Sweden. sara.regner@med.lu.se FAU - Manjer, J AU - Manjer J FAU - Appelros, S AU - Appelros S FAU - Hjalmarsson, C AU - Hjalmarsson C FAU - Sadic, J AU - Sadic J FAU - Borgstrom, A AU - Borgstrom A LA - eng PT - Journal Article DEP - 20081013 PL - Switzerland TA - Pancreatology JT - Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] JID - 100966936 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 103964-84-7 (PRSS2 protein, human) RN - 9002-08-8 (Trypsinogen) RN - 9007-41-4 (C-Reactive Protein) RN - EC 3.2.1.- (Amylases) RN - EC 3.4.- (Peptide Hydrolases) RN - EC 3.4.17.2 (Carboxypeptidase B) RN - EC 3.4.21.4 (Trypsin) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Amylases/blood MH - C-Reactive Protein/metabolism MH - Carboxypeptidase B/blood MH - Chemokine CCL2/blood/urine MH - Enzyme Activation MH - Female MH - Humans MH - *Inflammation MH - Male MH - Middle Aged MH - Pancreatitis/*classification/*enzymology/physiopathology MH - Peptide Hydrolases/*blood MH - Trypsin/blood MH - Trypsinogen/blood EDAT- 2008/10/14 09:00 MHDA- 2008/12/18 09:00 CRDT- 2008/10/14 09:00 PHST- 2007/11/22 00:00 [received] PHST- 2008/02/21 00:00 [accepted] PHST- 2008/10/14 09:00 [pubmed] PHST- 2008/12/18 09:00 [medline] PHST- 2008/10/14 09:00 [entrez] AID - S1424-3903(08)80092-0 [pii] AID - 10.1159/000161011 [doi] PST - ppublish SO - Pancreatology. 2008;8(6):600-7. doi: 10.1159/000161011. Epub 2008 Oct 13.